ClinVar Genomic variation as it relates to human health
NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met)
Variation ID: 14056 Accession: VCV000014056.21
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 11q13.2 11: 67612225 (GRCh38) [ NCBI UCSC ] 11: 67379696 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jul 3, 2015 Sep 16, 2024 Jun 29, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_007103.4:c.1268C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_009034.2:p.Thr423Met missense NM_001166102.2:c.1241C>T NP_001159574.1:p.Thr414Met missense NC_000011.10:g.67612225C>T NC_000011.9:g.67379696C>T NG_013353.1:g.10374C>T P49821:p.Thr423Met - Protein change
- T423M, T414M
- Other names
-
p.T423M:ACG>ATG
- Canonical SPDI
- NC_000011.10:67612224:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00001
The Genome Aggregation Database (gnomAD) 0.00004
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
LOC126861242 | - | - | - | GRCh38 | - | 128 |
NDUFV1 | - | - |
GRCh38 GRCh37 |
352 | 502 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
May 18, 2017 | RCV000015100.29 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Jun 29, 2024 | RCV000200093.11 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Oct 31, 2018 | RCV000763271.4 | |
Pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Jun 10, 2022 | RCV000735412.11 | |
Pathogenic (1) |
criteria provided, single submitter
|
Nov 28, 2022 | RCV002468969.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(May 18, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Mitochondrial complex I deficiency, nuclear type 1
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000611219.1
First in ClinVar: Feb 20, 2016 Last updated: Feb 20, 2016 |
|
|
Likely pathogenic
(Oct 31, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Mitochondrial complex I deficiency, nuclear type 1
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000893915.1
First in ClinVar: Mar 31, 2019 Last updated: Mar 31, 2019 |
|
|
Pathogenic
(Dec 31, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Mitochondrial complex I deficiency, nuclear type 1
Affected status: yes
Allele origin:
germline
|
Baylor Genetics
Accession: SCV000992792.1
First in ClinVar: Sep 21, 2019 Last updated: Sep 21, 2019 |
|
|
Pathogenic
(Jan 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Mitochondrial complex 1 deficiency, nuclear type 4
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002058177.1
First in ClinVar: Jan 15, 2022 Last updated: Jan 15, 2022 |
Comment:
Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000014056, PMID:10080174, PS1_S). Functional … (more)
Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000014056, PMID:10080174, PS1_S). Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product(PMID: 14662656, PS3_M).The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (PMID: 10080174, PM3_M). and co-segregated with Mitochondrial complex I deficiency, nuclear type 4 in multiple affected family members (PMID: 10080174, PP1_P). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.859, PP3_P). A missense variant is a common mechanism associated with Mitochondrial complex I deficiency (PP2_P). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000012, PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Cerebellar ataxia (present) , Falls (present) , Incomprehensible speech (present) , Global developmental delay (present) , Leukodystrophy (present)
|
|
Pathogenic
(Jun 10, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Mitochondrial complex 1 deficiency, nuclear type 4
Affected status: yes
Allele origin:
germline
|
DASA
Accession: SCV002526384.1
First in ClinVar: Jun 18, 2022 Last updated: Jun 18, 2022 |
Comment:
The c.1268C>T;p.(Thr423Met) missense change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 14056 ; PMID: 30090137; 10080174) … (more)
The c.1268C>T;p.(Thr423Met) missense change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 14056 ; PMID: 30090137; 10080174) - PS4.Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product (PMID: 26345448) - PS3_supporting. The variant is present at low allele frequencies population databases (rs121913659– gnomAD 0.0003295%; ABraOM no frequency - http://abraom.ib.usp.br/) -PM2_supporting. The p.(Thr423Met) was detected in trans with a Pathogenic variant (PMID: 30090137; 10080174) and found as compound heterozygous with another variant classified as Pathogenic (knowing the phase of each variant), in the analyzed case - PM3_strong. The variant co-segregated with disease in multiple affected family members (PMID: 10080174) - PP1. In summary, the currently available evidence indicates that the variant is Pathogenic (less)
Number of individuals with the variant: 1
Sex: male
Geographic origin: Brazil
|
|
Pathogenic
(Nov 28, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Leigh syndrome
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV002766344.1
First in ClinVar: Dec 24, 2022 Last updated: Dec 24, 2022 |
Comment:
Variant summary: NDUFV1 c.1268C>T (p.Thr423Met) results in a non-conservative amino acid change located in the NADH-ubiquinone oxidoreductase 51kDa subunit, iron-sulphur binding domain (IPR019575) of the … (more)
Variant summary: NDUFV1 c.1268C>T (p.Thr423Met) results in a non-conservative amino acid change located in the NADH-ubiquinone oxidoreductase 51kDa subunit, iron-sulphur binding domain (IPR019575) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251318 control chromosomes. c.1268C>T has been reported in the literature as biallelic compound heterozygous or homozygous genotypes in multiple individuals affected with Leigh Syndrome (example, PMID 33083013, 34716721, 10080174). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (example, PMID 26345448). The most pronounced variant effect results in absence of detectable complex I in an apparently homozygous (by cDNA sequencing), but compound heterozygous genotype due to a nonsense variant on the other allele that was not expressed. Eight clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. (less)
|
|
Pathogenic
(Jun 29, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000251947.12
First in ClinVar: Oct 11, 2015 Last updated: Sep 16, 2024 |
Comment:
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at a significant frequency in large population cohorts … (more)
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 17383918, 19041632, 17289351, 18435906, 18353897, 29948731, 30090137, 11579423, 20153825, 11181577, 16120313, 34807224, 31665838, 10080174, 21696386, 17600689, 10649489, 19703648, 19255735, 15901599, 18295330, 10330338, 29395179, 24704045, 11112787, 14662656, 16213125, 24524415, 30429455, 15981016, 22033105, 10862082, 10885663, 23631824, 22142868, 30055843, 26345448, 31216405, 33083013) (less)
|
|
Pathogenic
(Jan 08, 2014)
|
criteria provided, single submitter
Method: clinical testing
|
Mitochondrial complex I deficiency
Affected status: yes
Allele origin:
maternal
|
Courtagen Diagnostics Laboratory, Courtagen Life Sciences
Accession: SCV000236508.2
First in ClinVar: Jul 03, 2015 Last updated: Jul 03, 2015 |
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Mitochondrial complex I deficiency nuclear type 4
Affected status: yes
Allele origin:
germline
|
Centogene AG - the Rare Disease Company
Accession: SCV001424462.1
First in ClinVar: Jul 26, 2020 Last updated: Jul 26, 2020 |
|
|
Pathogenic
(Aug 07, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Mitochondrial complex 1 deficiency, nuclear type 4
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
Accession: SCV001429940.1
First in ClinVar: Aug 21, 2020 Last updated: Aug 21, 2020 |
Clinical Features:
Seizure (present) , Hypotonia (present) , Lactic acidosis (present) , Abnormal brainstem MRI signal intensity (present) , Motor delay (present) , Failure to thrive (present)
Sex: female
Tissue: blood
|
|
Pathogenic
(Dec 14, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002239527.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 423 of the NDUFV1 protein (p.Thr423Met). … (more)
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 423 of the NDUFV1 protein (p.Thr423Met). This variant is present in population databases (rs121913659, gnomAD 0.003%). This missense change has been observed in individuals with mitochondrial complex I deficiency (PMID: 10080174, 22644603, 30090137, 31665838). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 14056). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NDUFV1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Mar 01, 1999)
|
no assertion criteria provided
Method: literature only
|
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000035357.4
First in ClinVar: Apr 04, 2013 Last updated: Dec 16, 2018 |
Comment on evidence:
In 2 brothers with complex I deficiency nuclear type 4 (MC1DN4; 618225), Schuelke et al. (1999) identified compound heterozygosity for 2 mutations in the NDUFV1 … (more)
In 2 brothers with complex I deficiency nuclear type 4 (MC1DN4; 618225), Schuelke et al. (1999) identified compound heterozygosity for 2 mutations in the NDUFV1 gene: a 1268C-T transition inherited from the mother, resulting in a thr423-to-met substitution, and a 175C-T transition, resulting in an arg59-to-ter (R59X; 161015.0002) substitution inherited from the father, resulting in a premature stop codon in exon 3 and truncation of 91% of the mature protein. Nonsense-mediated messenger decay was demonstrated by the low abundance (3%) of the father's allelic transcripts in both children, as shown by restriction analysis of radioactive PCR fragments. The phenotype was a severe encephalopathy with death at ages 14 and 17 months, respectively. Neither cranial MRIs nor postmortem reports were available to confirm Leigh syndrome (256000). In a yeast model system, Varghese et al. (2015) found that expression of the T423M variant resulted in no detectable complex I assembly or activity, consistent with a severe pathogenic effect. (less)
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Natural History of Leigh Syndrome: A Study of Disease Burden and Progression. | Lim AZ | Annals of neurology | 2022 | PMID: 34716721 |
Genomic testing in 1019 individuals from 349 Pakistani families results in high diagnostic yield and clinical utility. | Cheema H | NPJ genomic medicine | 2020 | PMID: 33083013 |
[Clinical and genetic characteristics of 62 children with mitochondrial epilepsy]. | Han XD | Zhonghua er ke za zhi = Chinese journal of pediatrics | 2019 | PMID: 31665838 |
Late-Onset Leigh Syndrome due to NDUFV1 Mutation in a 10-Year-Old Boy Initially Presenting with Ataxia. | Incecik F | Journal of pediatric neurosciences | 2018 | PMID: 30090137 |
Characterization of clinically identified mutations in NDUFV1, the flavin-binding subunit of respiratory complex I, using a yeast model system. | Varghese F | Human molecular genetics | 2015 | PMID: 26345448 |
Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. | Koene S | Journal of inherited metabolic disease | 2012 | PMID: 22644603 |
Mitochondrial complex I mutations in Caenorhabditis elegans produce cytochrome c oxidase deficiency, oxidative stress and vitamin-responsive lactic acidosis. | Grad LI | Human molecular genetics | 2004 | PMID: 14662656 |
Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. | Schuelke M | Nature genetics | 1999 | PMID: 10080174 |
Text-mined citations for rs121913659 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.